Alpha Paradigm Partners’s Biogen BIIB Stock Holding History

Alpha Paradigm Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-288	Closed	-$77K	–	484
2022 Q3	$77K	Buy	+288	New	+$61.2K	0.03%	385
2022 Q2	–	Sell	-1,005	Closed	-$212K	–	507
2022 Q1	$212K	Sell	1,005 -2,128	-68%	-$463K	0.08%	332
2021 Q4	$752K	Buy	+3,133	New	+$806K	0.3%	96

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Alpha Paradigm Partners's BIIB Position: Q4 2022 in Review

Alpha Paradigm Partners sold out of Biogen (BIIB) in Q4 2022, closing a stake of 288 shares — an estimated $77K sold.

Alpha Paradigm Partners first reported a position in BIIB in Q4 2021 and held it in 3 quarters. The position peaked at $752K in Q4 2021. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

Alpha Paradigm Partners reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
Alpha Paradigm Partners sold 288 Biogen shares in Q4 2022, an estimated $77K.
Alpha Paradigm Partners first reported a position in Biogen in Q4 2021 and held it in 3 quarters.
Alpha Paradigm Partners's Biogen position peaked at $752K in Q4 2021.
1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.